IP Library Granted Patent US 9,040,282
Granted Patent B2
US 9,040,282 · App. 14/038,488 · Granted May 26, 2015

Producing dicarboxylic acids using polyketide synthases

Inventors: Leonard Katz (Oakland, CA); Jeffrey L Fortman (San Francisco, CA); Jay D Keasling (Berkeley, CA)
Assignee: The Regents of the University of California
C12N9/1029C12N9/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,282
App. No.
14/038,488
Granted
May 26, 2015
Kind
B2
Abstract

The present invention provides for a polyketide synthase (PKS) capable of synthesizing a dicarboxylic acid (diacid). Such diacids include diketide-diacids and triketide-diacids. The invention includes recombinant nucleic acid encoding the PKS, and host cells comprising the PKS. The invention also includes methods for producing the diacids.

Claims (14)

1. A recombinant polyketide synthase (PKS) capable of synthesizing a dicarboxylic acid (diacid), said PKS comprising a loading module containing a beta-keto acyl carrier protein synthase Q domain (KS Q ) lacking decarboxylase activity, one or more extender modules and a thioesterase (TE) domain.

2. The PKS of claim 1 , wherein said diacid is pentane-1,5-dioic acid, and said PKS has a loading module that utilizes malonate and a single extender module that has a malonate-specific acyltransferase (AT) domain and a full set of reduction domains.

3. The PKS of claim 2 , wherein the loading module is from spiromycin, the single extender module is module 5 or module 6 from nystatin PKS or module 3 from the oligomycin PKS, and the TE domain is from erythromycin PKS.

4. The PKS of claim 1 , wherein said diacid is heptane-1,7-dioic acid; and said PKS has a loading module that utilizes malonate; a first and a second extender module, each of which has a malonate-specific acyltransferase (AT) domain; and a full set of reduction domains.

5. The PKS of claim 4 , wherein the loading module is from spiromycin, the first extender module is module 5 or module 6 from nystatin PKS or module 3 from the oligomycin PKS, the second extender module is module 5 from the epothilone PKS, and the TE domain is from erythromycin PKS.

6. The PKS of claim 1 , wherein said PKS comprises the loading module and module 1 of the spiramycin, oligomycin, or primaricin PKS; and the TE domain from erythromycin PKS or the TE domain encoded by the monCII gene; wherein the KS Q domain of the loading module is deleted or modified to inactivate the decarboxylase activity.

7. The PKS of claim 1 , wherein the diacid comprises from 1 to 10 ketide units.

8. The PKS of claim 7 , wherein the diacid comprises from 1 to 6 ketide units.

9. The PKS of claim 8 , wherein the diacid comprises from 1 to 3 ketide units.

10. The PKS of claim 9 , wherein the diacid is one described in Tables 2A-F and Tables 3A-KK.

11. A host cell comprising the PKS of claim 1 .

12. The host cell of claim 11 , wherein the host cell is a prokaryotic host cell.

13. The host cell of claim 12 , wherein the prokaryotic host cell is an E. coli or a Streptomyces sp. cell.

14. The host cell of claim 11 , wherein the host cell is a yeast host cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2015
From: KATZ, LEONARD; FORTMAN, JEFFREY L.; KEASLING, JAY D.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 035714/0805 →
CONFIRMATORY LICENSE Recorded Apr 24, 2014
From: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 032798/0043 →
Continuity (3)
Division 12922204
Provisional Application 61040584 · Mar 28, 2008
Related Publication 20140030789A1 · Jan 30, 2014